DAVID PISELLI: Open Payments
NPI 1982333845 · WEST HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 35 payments from 5 companies in 2025. Trend: 2023 $1,071 · 2024 $564 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 17 | $298 |
| AstraZeneca Pharmaceuticals LP | 8 | $169 |
| Corium, LLC | 6 | $89 |
| Novo Nordisk Inc | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Qelbree, Azstarys, AIRSUPRA, Ozempic, FARXIGA, BREZTRI, REXULTI.
Industry payments across CT — which companies pay providers there.
